Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 481 AL 495

Calcium balance through mutual orchestrated inter-organelle communication: A pleiotropic target for combating Alzheimer's disease

Hossain MK, Chae HJ.

Neurochem Int. 2025 Jan;182:105905. doi: 10.1016/j.neuint.2024.105905. Epub 2024 Nov 19.

The role of ferritinophagy and ferroptosis in Alzheimer's disease

Chen Z, Zheng N, Wang F, Zhou Q, Chen Z, Xie L, Sun Q, Li L, Li B.

Brain Res. 2025 Mar 1;1850:149340. doi: 10.1016/j.brainres.2024.149340. Epub 2024 Nov 23.

Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein

Antony D, Sheth P, Swenson A, Smoller C, Maguire K, Grossberg G.

Expert Opin Pharmacother. 2025 Jan;26(1):63-73. doi: 10.1080/14656566.2024.2438317. Epub 2024 Dec 4.

An overview on the impact of viral pathogens on Alzheimer's disease

AmeliMojarad M, AmeliMojarad M, Cui X.

Ageing Res Rev. 2025 Feb;104:102615. doi: 10.1016/j.arr.2024.102615. Epub 2024 Dec 2.

The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review

Zeng HX, Qin SJ, Andersson J, Li SP, Zeng QG, Li JH, Wu QZ, Meng WJ, Oudin A, Kanninen KM, Jalava P, Dong GH, Zeng XW.

Environ Pollut. 2025 Feb 1;366:125440. doi: 10.1016/j.envpol.2024.125440. Epub 2024 Dec 2.

Advances in the structural modification of Alzheimer's disease drug - Huperzine A

Zhu X, Xu JB, Gao F, Wan LX.

Bioorg Chem. 2025 Jan;154:108012. doi: 10.1016/j.bioorg.2024.108012. Epub 2024 Nov 29.

Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond

Sandhof CA, Murray HFB, Silva MC, Haggarty SJ.

Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.

Exerkines mitigating Alzheimer's disease progression by regulating inflammation: Focusing on macrophage/microglial NLRP3 inflammasome pathway

Cheon J, Kwon S, Kim M.

Alzheimers Dement. 2025 Feb;21(2):e14432. doi: 10.1002/alz.14432. Epub 2024 Dec 6.

Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective

Pal C.

Biochim Biophys Acta Mol Basis Dis. 2025 Mar;1871(3):167617. doi: 10.1016/j.bbadis.2024.167617. Epub 2024 Dec 8.

Neuroinflammation in Alzheimer disease

Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Wagner M, Neher JJ, Cunningham C, Singhrao SK, Prinz M, Glass CK, Schlachetzki JCM, Butovsky O, Kleemann K, De Jaeger PL, Scheiblich H, Brown GC, Landreth G, Moutinho M, Grutzendler J, Gomez-Nicola D, McManus RM, Andreasson K, Ising C, Karabag D, Baker DJ, Liddelow SA, Verkhratsky A, Tansey M, Monsonego A, Aigner L, Dorothée G, Nave KA, Simons M, Constantin G, Rosenzweig N, Pascual A, Petzold GC, Kipnis J, Venegas C, Colonna M, Walter J, Tenner AJ, O'Banion MK, Steinert JR, Feinstein DL, Sastre M, Bhaskar K, Hong S, Schafer DP, Golde T, Ransohoff RM, Morgan D, Breitner J, Mancuso R, Riechers SP.

Nat Rev Immunol. 2025 May;25(5):321-352. doi: 10.1038/s41577-024-01104-7. Epub 2024 Dec 9.

Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment

Tripathi S, Sharma Y, Kumar D.

Protein Pept Lett. 2025;32(1):2-17. doi: 10.2174/0109298665348075241121071614.

Electrophysiological insights into Alzheimer's disease: A review of human and animal studies

Calvin-Dunn KN, Mcneela A, Leisgang Osse A, Bhasin G, Ridenour M, Kinney JW, Hyman JM.

Neurosci Biobehav Rev. 2025 Feb;169:105987. doi: 10.1016/j.neubiorev.2024.105987. Epub 2024 Dec 26.

Hippocampal Synaptic Plasticity: Integrating Memory and Anxiety Impairments in the Early Stages of Alzheimer's Disease

Good MA, Bannerman DM.

Curr Top Behav Neurosci. 2025;69:27-48. doi: 10.1007/7854_2024_565.

Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics

Chunhui G, Yanqiu Y, Jibing C, Ning L, Fujun L.

Metab Brain Dis. 2025 Jan 4;40(1):84. doi: 10.1007/s11011-024-01520-7.

Intranasal amyloid model of Alzheimer's disease - potential opportunities and challenges

Singh RK.

Pharmacol Rep. 2025 Apr;77(2):425-433. doi: 10.1007/s43440-024-00692-4. Epub 2025 Jan 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias